Literature DB >> 24431811

Percutaneous Radiofrequency Rhizotomy in Treatment of Trigeminal neuralgia: A Prospective Study.

Madan Nanjappa1, S V Kumaraswamy1, R Keerthi1, D P Ashwin1, A L Gopinath1, M A Reyazulla1, K B Hemavathi1.   

Abstract

INTRODUCTION: Trigeminal neuralgia (TN) often called as "Tic douloureux" is a syndrome characterized by paroxysmal facial pain, is one of the most painful and debilitating craniofacial pain disorders. The controversy regarding the etiology and treatment of TN still exists.
OBJECTIVE: To evaluate the effectiveness of percutaneous radiofrequency rhizotomy (PRR) for TN, after failure of pharmacological management.
METHOD: A nonrandomized, non comparative, descriptive, in vivo study of 15 patients with TN of maxillary and mandibular divisions of trigeminal nerve and patients with pain refractory to pharmacological management were done. It was performed as an O.P.D procedure. A routine follow up was done in all cases for 1 year.
RESULTS: In a total of 15 patients, 8 female and 7 male patients were enrolled for the study. Early pain relief (immediately, postoperatively to 6 month) classified as excellent or good (successful), occurred in 12 of 15 patients (80 %). Fair or poor pain relief (unsuccessful) occurred in three patients (20 %).There was no mortalities and no major morbidity.
SUMMARY: It was found that surgical treatment with PRR is a safe and effective way to manage patients with TN in whom pharmacologic therapy is either ineffective or not tolerated, with low side effects which are well tolerated.

Entities:  

Keywords:  Percutaneous; Rhizotomy; Trigeminal neuralgia

Year:  2012        PMID: 24431811      PMCID: PMC3589509          DOI: 10.1007/s12663-012-0365-7

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  9 in total

Review 1.  Trigeminal neuralgia: mechanisms of treatment.

Authors:  R B Tenser
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

Review 2.  Percutaneous balloon compression of the trigeminal nerve.

Authors:  J A Brown; J J Gouda
Journal:  Neurosurg Clin N Am       Date:  1997-01       Impact factor: 2.509

3.  Leksell Gamma Knife treatment of tic douloureux.

Authors:  R W Rand
Journal:  Neurosurg Clin N Am       Date:  1997-01       Impact factor: 2.509

4.  Trigeminal neuralgia: a comparison of the results of percutaneous rhizotomy and microvascular decompression.

Authors:  G G Ferguson; D C Brett; S J Peerless; H W Barr; J P Girvin
Journal:  Can J Neurol Sci       Date:  1981-08       Impact factor: 2.104

5.  Considerations on the cause and treatment of trigeminal neuralgia.

Authors:  L R Carney
Journal:  Neurology       Date:  1967-12       Impact factor: 9.910

6.  Radiofrequency percutaneous Gasserian ganglion lesions. Results in 140 patients with trigeminal pain.

Authors:  B M Onofrio
Journal:  J Neurosurg       Date:  1975-02       Impact factor: 5.115

7.  Percutaneous stereotactic differential radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia.

Authors:  S J Scrivani; D A Keith; E S Mathews; L B Kaban
Journal:  J Oral Maxillofac Surg       Date:  1999-02       Impact factor: 1.895

8.  Long-term efficacy of microvascular decompression in trigeminal neuralgia.

Authors:  K J Burchiel; H Clarke; M Haglund; J D Loeser
Journal:  J Neurosurg       Date:  1988-07       Impact factor: 5.115

9.  Invasive dental treatment, pain reports, and disease conviction in chronic facial pain patients. A retrospective study.

Authors:  M Allerbring; G Haegerstam
Journal:  Acta Odontol Scand       Date:  1995-02       Impact factor: 2.331

  9 in total
  2 in total

Review 1.  Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures.

Authors:  Carolina Venda Nova; Joanna M Zakrzewska; Sarah R Baker; Richeal Ni Riordain
Journal:  World Neurosurg X       Date:  2020-01-27

Review 2.  Radiosurgery in periodontics: Have we forgotten it?

Authors:  Duddukuri Hema; Jammula Surya Prasanna
Journal:  J Indian Soc Periodontol       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.